吳承宇 博士

Dr. Cheng-Yeu Wu

中心副研究員

學歷

2001 Department ofmicrobiology and Immunology of Yang-Ming, Taiwan

(2001 Ph. D.)
1991 Genetic EngineeringCenter, Department of Botany, National Chung-

HsingUniversity, Taiwan (1991M. S.)

經歷

2009-2017 長庚大學分子與臨床免疫中心 助理研究員

2017-至今 長庚大學分子與臨床免疫中心 副研究員

研究方向

以線蟲為模型探討抗糖尿病藥物 (Metforminand acarbose)、膳食補充劑 (Berberineand medicinal mushroom)、 膽固醇控制藥物 ( Lovastatin) 對健康及生命週期的影響

研究膳食補充劑調節衰老和先天免疫的微生物群變化的模型系統
 

研究論文(選錄)

• Wu, C. Y., Martel, J., and Young, J. D. (2020) Ectopic calcification and formation of mineralo-organic particles in arteries of diabetic subjects. Sci Rep 10, 8545
• Wu, C.-Y., Martel, J., and Young, J. D. (2018) Comprehensive organic profiling of biological particles derived from blood. Sci Rep 8 
• Wu, C. Y., Young, D., Martel, J., and Young, J. D. (2015) A story told by a single nanoparticle in the body fluid: demonstration of dissolution-reprecipitation of nanocrystals in a biological system. Nanomedicine (Lond), 1-18
• Wu, C. Y., Martel, J., Cheng, W. Y., He, C. C., Ojcius, D. M., and Young, J. D. (2013) Membrane Vesicles Nucleate Mineralo-organic Nanoparticles and Induce Carbonate Apatite Precipitation in Human Body Fluids. JBC 288, 30571-30584